BMS and Array BioPharma partner up to tackle colorectal cancer
May 30, 2017Manufacturing and Production, Research and Development, Sales and Marketing Array Biopharma, BMS, Bristol-Myers Squibb
Bristol-Myers Squibb and Array BioPharma have announced they are to join forces as part of a new clinical research partnership …
Glenmark greenlighted to market hypertension generic in US
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, Glenmark, generic, hypertension
Glenmark Pharmaceuticals has revealed it has been awarded final approval by the FDA to market hypertension treatment nebivolol, a generic …
Beta blockers offer little to no benefit for heart attack patients, study suggests
May 30, 2017Manufacturing and Production, Research and Development beta-blockers, heart attack
New research from the University of Leeds has called into question the prevalent practice of prescribing beta blockers for heart …
FDA approves Novartis’ Zykadia as first-line lung cancer treatment
May 30, 2017Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis
The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …
Gene-editing tool CRISPR found to cause unintentional mutations in live animal models
May 30, 2017Manufacturing and Production, Research and Development crispr
Gene-editing has been heralded as a wonder tool which could lead to huge advances in a wide range of treatment …
Global Pricing Innovations and Pricing360 announce new strategic partnership
May 30, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
London, May 30, 2017 – Global Pricing Innovations (GPI), the pricing and intelligence experts for the life sciences industry and …
WHO elects first African Director General
May 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Superbugs in the supply chain
May 26, 2017Medical Communications Antibiotics, Changing Markets, China, IMAGE: Changing Markets, Superbugs
Bad Manufacturing Practices: Changing Markets examines China’s role in the antibiotics supply chain and the damaging pollution that results from …
New FDA Commissioner reveals strategy to drive down drug prices
May 26, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb, Trump, pricing
Deregulation, faster access and cheaper drug prices very quickly became the rallying cry for the Trump administration in the life …
Furore over DNA testing company’s licensing of consumers’ data
May 26, 2017Medical Communications 23andME, Ancestry, DNA, DNA testing, genetic information
A company that assesses DNA is dealing with the repercussions of public outcry after a data protection lawyer highlighted a …
Top Ten most popular articles on Pharmafile.com this week
May 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Among other things, it’s been a week characterised by safety failures as three of our most popular stories centred on …
Puma Biotech’s breast cancer drug gets FDA committee nod
May 25, 2017Medical Communications, Sales and Marketing Puma Biotech, breast cancer, neratinib
Puma Biotechnology breast cancer drug that could be used to reduce the risk of disease recurrence has been boosted by …
Pharmaceutical companies and patient advocacy groups: Natural allies in the support of patients
May 25, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Takeda oncology, patient advocacy
As published in the special Market Access section of the latest issue of Pharmafocus, Liz Lewis, Chief Counsel & Compliance …
Neurocrine’s Ingrezza flops in Tourette’s for second time
May 25, 2017Research and Development, Sales and Marketing Neurocrine Biosciences, tourette's
Neurocrine’s Tourette’s therapy Ingrezza (valbenazine) has been hit with yet another setback, flopping in a Phase 2 trial of paediatric …
Cannabidiol drug found to aid in devastating childhood epilepsy condition
May 25, 2017Research and Development GW Pharmaceuticals, cannabidoil, epilepsy
A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
Tedros Adhanom Ghebreyesus becomes WHO Director General
May 25, 2017Medical Communications WHO
Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …
Inovio posts “exceptional” results for HIV vaccine
May 25, 2017Research and Development AIDS, HIV, HIV vaccine, Vaccine
Inovio Pharmaceuticals has been working on HIV vaccines for a long time and, eight years after signing a $25 million …
26 die after attempting to replace Abbott’s blood pump controller themselves
May 24, 2017Medical Communications, Sales and Marketing Abbott, FDA, Medical device, deaths
At least 26 advanced heart failure patients have died and 19 have been injured by attempting to change the controller …
MSD receives first FDA approval based on specific genetic feature
May 24, 2017Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda
In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
Antibiotics found to fail in quarter of pneumonia patients
May 24, 2017Research and Development Antibiotics, antibiotic resistance, pneumonia
A new study that emerged from the 2017 American Thoracic Society International Conference revealed that 22.1% of patients who were …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
